blog | MapLight Therapeutics

Skip to content

Back to Blog

Back to Blog

Subscribe to our Newsletter

Nasdaq, MapLight Therapeutics

MapLight Therapeutics Prices IPO Weeks Ahead of Trading in Rare SEC Workaround

$Picture of {{ content.blog_author.display_name }}$ Eric Friedman

Oct 8, 2025 4:15:17 PM

Subscribe to our Newsletter

Email

1500 N. Grant Street Suite 4128 Denver, CO 80203

NONE OF THE CONTENT PUBLISHED ON THE WEBSITE OR MOBILE APP CONSTITUTES A RECOMMENDATION, SOLICITATION, ENDORSEMENT, OR OFFER BY IPO PROPHET™ OR ITS AFFILIATES TO BUY OR SELL ANY SECURITIES, FUTURES, OPTIONS, OR OTHER FINANCIAL INSTRUMENTS, OR PROVIDE ANY INVESTMENT ADVICE OR SERVICE.